Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes

被引：82

作者：

Harenberg, J ^{[1
]}

机构：

[1] Univ Hosp, Dept Internal Med & Geriatr, Mannheim, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 04期

关键词：

D O I：

10.1111/j.1538-7933.2004.00647.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：547 / 550

页数：4

相关论文

共 27 条

[11]

HARENBERG J, 1989, NOUV REV FR HEMATOL, V31, P363

[12]

HARENBERG J, 1988, THROMB HAEMOSTASIS, V60, P377

[13]

HARENBERG J, 1989, THROMB HAEMOSTASIS, V61, P357

[14] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis [J].

Harenberg, J ;

Stehle, G ;

Blauth, M ;

Huck, K ;

Mall, K ;

Heene, DL .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01) :83-90

[15] Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety [J].

Hirsh, J ;

Warkentin, TE ;

Shaughnessy, SG ;

Anand, SS ;

Halperin, JL ;

Raschke, R ;

Granger, C ;

Ohman, EM ;

Dalen, JE .

CHEST, 2001, 119 (01) :64S-94S

[16]

HOLMSTROM M, 1992, THROMB RES, V67, P49

[17] SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].

HULL, RD ;

RASKOB, GE ;

PINEO, GF ;

GREEN, D ;

TROWBRIDGE, AA ;

ELLIOTT, CG ;

LERNER, RG ;

HALL, J ;

SPARLING, T ;

BRETTELL, HR ;

NORTON, J ;

CARTER, CJ ;

GEORGE, R ;

MERLI, G ;

WARD, J ;

MAYO, W ;

ROSENBLOOM, D ;

BRANT, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (15) :975-982

[18]

Laposata M, 1998, ARCH PATHOL LAB MED, V122, P799

[19]

LEVINE MN, 1989, THROMB HAEMOSTASIS, V62, P940

[20]

LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186